Febuxostat, a Xanthine-Oxidase-Inhibitor, Suppresses the Structural Remodeling in Atrium through Anti-Oxidative Effect in the Canine Model of Atrial Fibrillation.
Author
Individual or Joint
Journal
Annual Scientific Meeting of the Japanese Circulation Society